300 related articles for article (PubMed ID: 20473892)
21. The phospholipase D inhibitor FIPI potently blocks EGF-induced calcium signaling in human breast cancer cells.
Stricker HM; Rommerswinkel N; Keil S; Gnoth SA; Niggemann B; Dittmar T
Cell Commun Signal; 2021 Apr; 19(1):43. PubMed ID: 33832505
[TBL] [Abstract][Full Text] [Related]
22. Phospholipase D2 regulates endothelial permeability through cytoskeleton reorganization and occludin downregulation.
Zeiller C; Mebarek S; Jaafar R; Pirola L; Lagarde M; Prigent AF; Némoz G
Biochim Biophys Acta; 2009 Jul; 1793(7):1236-49. PubMed ID: 19371764
[TBL] [Abstract][Full Text] [Related]
23. Phosphatidic acid, phospholipase D and tumorigenesis.
Gomez-Cambronero J
Adv Biol Regul; 2014 Jan; 54():197-206. PubMed ID: 24103483
[TBL] [Abstract][Full Text] [Related]
24. Temporal production of the signaling lipid phosphatidic acid by phospholipase D2 determines the output of extracellular signal-regulated kinase signaling in cancer cells.
Zhang F; Wang Z; Lu M; Yonekubo Y; Liang X; Zhang Y; Wu P; Zhou Y; Grinstein S; Hancock JF; Du G
Mol Cell Biol; 2014 Jan; 34(1):84-95. PubMed ID: 24164897
[TBL] [Abstract][Full Text] [Related]
25. Involvement of phospholipase D in insulin-like growth factor-I-induced activation of extracellular signal-regulated kinase, but not phosphoinositide 3-kinase or Akt, in Chinese hamster ovary cells.
Banno Y; Takuwa Y; Yamada M; Takuwa N; Ohguchi K; Hara A; Nozawa Y
Biochem J; 2003 Jan; 369(Pt 2):363-8. PubMed ID: 12385647
[TBL] [Abstract][Full Text] [Related]
26. Role of phospholipase D in parathyroid hormone type 1 receptor signaling and trafficking.
Garrido JL; Wheeler D; Vega LL; Friedman PA; Romero G
Mol Endocrinol; 2009 Dec; 23(12):2048-59. PubMed ID: 19837945
[TBL] [Abstract][Full Text] [Related]
27. Overexpression of phospholipase D enhances matrix metalloproteinase-2 expression and glioma cell invasion via protein kinase C and protein kinase A/NF-kappaB/Sp1-mediated signaling pathways.
Park MH; Ahn BH; Hong YK; Min do S
Carcinogenesis; 2009 Feb; 30(2):356-65. PubMed ID: 19126647
[TBL] [Abstract][Full Text] [Related]
28. Differential regulation of apoptosis by caspase-mediated cleavage of phospholipase D isozymes.
Jang YH; Ahn BH; Namkoong S; Kim YM; Jin JK; Kim YS; Min do S
Cell Signal; 2008 Dec; 20(12):2198-207. PubMed ID: 18694819
[TBL] [Abstract][Full Text] [Related]
29. Selective induction of phospholipase D1 in pathogen-activated human monocytes.
Locati M; Riboldi E; Bonecchi R; Transidico P; Bernasconi S; Haribabu B; Morris AJ; Mantovani A; Sozzani S
Biochem J; 2001 Aug; 358(Pt 1):119-25. PubMed ID: 11485559
[TBL] [Abstract][Full Text] [Related]
30. Structure and regulation of human phospholipase D.
Bowling FZ; Frohman MA; Airola MV
Adv Biol Regul; 2021 Jan; 79():100783. PubMed ID: 33495125
[TBL] [Abstract][Full Text] [Related]
31. The progesterone receptor as a transcription factor regulates phospholipase D1 expression through independent activation of protein kinase A and Ras during 8-Br-cAMP-induced decidualization in human endometrial stromal cells.
Cho JH; Yoon MS; Koo JB; Kim YS; Lee KS; Lee JH; Han JS
Biochem J; 2011 May; 436(1):181-91. PubMed ID: 21284604
[TBL] [Abstract][Full Text] [Related]
32. PLD1 is overexpressed in an ER-negative MCF-7 cell line variant and a subset of phospho-Akt-negative breast carcinomas.
Gozgit JM; Pentecost BT; Marconi SA; Ricketts-Loriaux RS; Otis CN; Arcaro KF
Br J Cancer; 2007 Sep; 97(6):809-17. PubMed ID: 17726467
[TBL] [Abstract][Full Text] [Related]
33. IL-15 promotes osteoclastogenesis via the PLD pathway in rheumatoid arthritis.
Park MK; Her YM; Cho ML; Oh HJ; Park EM; Kwok SK; Ju JH; Park KS; Min DS; Kim HY; Park SH
Immunol Lett; 2011 Sep; 139(1-2):42-51. PubMed ID: 21620893
[TBL] [Abstract][Full Text] [Related]
34. Phosphatidic acid-mediated activation and translocation to the cell surface of sialidase NEU3, promoting signaling for cell migration.
Shiozaki K; Takahashi K; Hosono M; Yamaguchi K; Hata K; Shiozaki M; Bassi R; Prinetti A; Sonnino S; Nitta K; Miyagi T
FASEB J; 2015 May; 29(5):2099-111. PubMed ID: 25678627
[TBL] [Abstract][Full Text] [Related]
35. Expression and regulation of phospholipase D isoforms in mammalian cell lines.
Gibbs TC; Meier KE
J Cell Physiol; 2000 Jan; 182(1):77-87. PubMed ID: 10567919
[TBL] [Abstract][Full Text] [Related]
36. Effects of active and inactive phospholipase D2 on signal transduction, adhesion, migration, invasion, and metastasis in EL4 lymphoma cells.
Knoepp SM; Chahal MS; Xie Y; Zhang Z; Brauner DJ; Hallman MA; Robinson SA; Han S; Imai M; Tomlinson S; Meier KE
Mol Pharmacol; 2008 Sep; 74(3):574-84. PubMed ID: 18523140
[TBL] [Abstract][Full Text] [Related]
37. Phospholipase D inhibitors reduce human prostate cancer cell proliferation and colony formation.
Noble AR; Maitland NJ; Berney DM; Rumsby MG
Br J Cancer; 2018 Jan; 118(2):189-199. PubMed ID: 29136407
[TBL] [Abstract][Full Text] [Related]
38. Down-regulation of MicroRNAs (MiRs) 203, 887, 3619 and 182 Prevents Vimentin-triggered, Phospholipase D (PLD)-mediated Cancer Cell Invasion.
Fite K; Gomez-Cambronero J
J Biol Chem; 2016 Jan; 291(2):719-30. PubMed ID: 26567912
[TBL] [Abstract][Full Text] [Related]
39. Structural Insights for Drugs Developed for Phospholipase D Enzymes.
Stieglitz KA
Curr Drug Discov Technol; 2018; 15(2):81-93. PubMed ID: 28814238
[TBL] [Abstract][Full Text] [Related]
40. Phospholipase D1 activation through Src and Ras is involved in basic fibroblast growth factor-induced neurite outgrowth of H19-7 cells.
Oh DY; Park SY; Cho JH; Lee KS; Min do S; Han JS
J Cell Biochem; 2007 May; 101(1):221-34. PubMed ID: 17146759
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
